[M03AB01, succinylcholine, Succinylcholine may increase the neurotoxic activities of Cycloserine.]
[N05AL01, sulpiride, Cycloserine may increase the neurotoxic activities of Sulpiride.]
[L01CB02, teniposide, Cycloserine may increase the neurotoxic activities of Teniposide.]
[S01HA03, tetracaine, The risk or severity of methemoglobinemia can be increased when Cycloserine is combined with Tetracaine.]
[N05AE05, lurasidone, Cycloserine may increase the neurotoxic activities of Lurasidone.]
[R06AD03, thiethylperazine, Cycloserine may increase the neurotoxic activities of Thiethylperazine.]
[N05AB08, thioproperazine, Cycloserine may increase the neurotoxic activities of Thioproperazine.]
[N05AC02, thioridazine, Cycloserine may increase the neurotoxic activities of Thioridazine.]
[N05AF04, thiothixene, Cycloserine may increase the neurotoxic activities of Thiothixene.]
[N05AL03, tiapride, Cycloserine may increase the neurotoxic activities of Tiapride.]
[N05AB06, trifluoperazine, Cycloserine may increase the neurotoxic activities of Trifluoperazine.]
[N05AD02, trifluperidol, Cycloserine may increase the neurotoxic activities of Trifluperidol.]
[N05AA05, triflupromazine, Cycloserine may increase the neurotoxic activities of Triflupromazine.]
[R06AD01, trimeprazine, Cycloserine may increase the neurotoxic activities of Alimemazine.]
[N06AA06, trimipramine, Cycloserine may increase the neurotoxic activities of Trimipramine.]
[M03AA02, tubocurarine, Cycloserine may increase the neurotoxic activities of Tubocurarine.]
[L01CA02, vincristine, Cycloserine may increase the neurotoxic activities of Vincristine.]
[B01AA03, warfarin, The risk or severity of bleeding can be increased when Cycloserine is combined with Warfarin.]
[N05AF05, zuclopenthixol, Cycloserine may increase the neurotoxic activities of Zuclopenthixol.]
[N05AE04, ziprasidone, Ziprasidone may increase the neurotoxic activities of Cycloserine.]
[N01AA01, ethyl ether, Cycloserine may increase the neurotoxic activities of Diethyl ether.]
[N05AD07, benperidol, Cycloserine may increase the neurotoxic activities of Benperidol.]
[R02AD01, benzocaine, The risk or severity of methemoglobinemia can be increased when Cycloserine is combined with Benzocaine.]
[P03AX06, benzyl alcohol, The risk or severity of methemoglobinemia can be increased when Cycloserine is combined with Benzyl alcohol.]
[B01AA07, acenocoumarol, The risk or severity of bleeding can be increased when Cycloserine is combined with Acenocoumarol.]
[N05AA04, acepromazine, Cycloserine may increase the neurotoxic activities of Acepromazine.]
[B01AA01, dicumarol, The risk or severity of bleeding can be increased when Cycloserine is combined with Dicoumarol.]
[B01AA11, tioclomarol, The risk or severity of bleeding can be increased when Cycloserine is combined with Tioclomarol.]
[N05AX16, brexpiprazole, Cycloserine may increase the neurotoxic activities of Brexpiprazole.]
[N05AX15, cariprazine, Cycloserine may increase the neurotoxic activities of Cariprazine.]
[N05AB07, acetophenazine, Cycloserine may increase the neurotoxic activities of Acetophenazine.]
[N06AA19, amineptin, Cycloserine may increase the neurotoxic activities of Amineptine.]
[N05AX17, pimavanserin, Cycloserine may increase the neurotoxic activities of Pimavanserin.]
[N01BB01, bupivacaine, The risk or severity of methemoglobinemia can be increased when Cycloserine is combined with Bupivacaine.]
[S01HA02, benoxinate, The risk or severity of methemoglobinemia can be increased when Cycloserine is combined with Oxybuprocaine.]
[A02BX12, bismuth subnitrate, Cycloserine may increase the neurotoxic activities of Bismuth subnitrate.]
[N05AD06, bromperidol, Cycloserine may increase the neurotoxic activities of Bromperidol.]
[N06AA15, butriptyline, Cycloserine may increase the neurotoxic activities of Butriptyline.]
[N01BX04, capsaicin, The risk or severity of methemoglobinemia can be increased when Cycloserine is combined with Capsaicin.]
[N01BA04, chloroprocaine, The risk or severity of methemoglobinemia can be increased when Cycloserine is combined with Chloroprocaine.]
[N05AA06, cyamemazine, Cycloserine may increase the neurotoxic activities of Cyamemazine.]
[M03BX08, cyclobenzaprine, Cycloserine may increase the neurotoxic activities of Cyclobenzaprine.]
[R02AD04, dyclonine, The risk or severity of methemoglobinemia can be increased when Cycloserine is combined with Dyclonine.]
[N05AA01, chlorpromazine, Cycloserine may increase the neurotoxic activities of Chlorpromazine.]
[N05AF03, chlorprothixene, Cycloserine may increase the neurotoxic activities of Chlorprothixene.]
[L01FX21, naxitamab, Cycloserine may increase the neurotoxic activities of Naxitamab.]
[J01FF01, clindamycin, Cycloserine may increase the neurotoxic activities of Clindamycin.]
[N01BB10, levobupivacaine, The risk or severity of methemoglobinemia can be increased when Cycloserine is combined with Levobupivacaine.]
[N06AA04, clomipramine, Cycloserine may increase the neurotoxic activities of Clomipramine.]
[N05AH06, clothiapine, Cycloserine may increase the neurotoxic activities of Clothiapine.]
[N05AH02, clozapine, Cycloserine may increase the neurotoxic activities of Clozapine.]
[S02DA02, cocaine, The risk or severity of methemoglobinemia can be increased when Cycloserine is combined with Cocaine.]
[N05AD03, metylperon, Cycloserine may increase the neurotoxic activities of Melperone.]
[L01AA01, cyclophosphamide, Cycloserine may increase the neurotoxic activities of Cyclophosphamide.]
[S01XA18, cyclosporine, Cyclosporine may increase the neurotoxic activities of Cycloserine.]
[M03AC11, cisatracurium, Cycloserine may increase the neuromuscular blocking activities of Cisatracurium.]
[N06AA01, desipramine, Cycloserine may increase the neurotoxic activities of Desipramine.]
[R02AA19, phenol, The risk or severity of methemoglobinemia can be increased when Cycloserine is combined with Phenol.]
[N06AA08, dibenzepin, Cycloserine may increase the neurotoxic activities of Dibenzepin.]
[S02DA04, dibucaine, The risk or severity of methemoglobinemia can be increased when Cycloserine is combined with Cinchocaine.]
[J05AF02, didanosine, Cycloserine may increase the neurotoxic activities of Didanosine.]
[N05AD05, pipamperone, Cycloserine may increase the neurotoxic activities of Pipamperone.]
[D04AB07, pramoxine, The risk or severity of methemoglobinemia can be increased when Cycloserine is combined with Pramocaine.]
[S01HA04, proparacaine, The risk or severity of methemoglobinemia can be increased when Cycloserine is combined with Proparacaine.]
[R06AA02, diphenhydramine, The risk or severity of methemoglobinemia can be increased when Cycloserine is combined with Diphenhydramine.]
[N06AA23, quinupramine, Cycloserine may increase the neurotoxic activities of Quinupramine.]
[N05AL04, remoxipride, Cycloserine may increase the neurotoxic activities of Remoxipride.]
[N05AX08, risperidone, Cycloserine may increase the neurotoxic activities of Risperidone.]
[N01BB09, ropivacaine, The risk or severity of methemoglobinemia can be increased when Cycloserine is combined with Ropivacaine.]
[N06AA16, dothiepin, Cycloserine may increase the neurotoxic activities of Dosulepin.]
[N06AA12, doxepin, Cycloserine may increase the neurotoxic activities of Doxepin.]
[N05AD08, droperidol, Cycloserine may increase the neurotoxic activities of Droperidol.]
[N05AL02, sultopride, Cycloserine may increase the neurotoxic activities of Sultopride.]
[N05AB05, thiopropazate, Cycloserine may increase the neurotoxic activities of Thiopropazate.]
[N06AX14, tianeptine, Cycloserine may increase the neurotoxic activities of Tianeptine.]
[N05AL06, veralipride, Cycloserine may increase the neurotoxic activities of Veralipride.]
[L01CA04, vinorelbine, Cycloserine may increase the neurotoxic activities of Vinorelbine.]
[N05AX11, zotepine, Cycloserine may increase the neurotoxic activities of Zotepine.]
[C01BG01, moricizine, Cycloserine may increase the neurotoxic activities of Moricizine.]
[J04AD03, ethionamide, The risk or severity of adverse effects can be increased when Ethionamide is combined with Cycloserine.]
[N01BX01, ethyl chloride, The risk or severity of methemoglobinemia can be increased when Cycloserine is combined with Ethyl chloride.]
[M01AC06, meloxicam, The risk or severity of methemoglobinemia can be increased when Cycloserine is combined with Meloxicam.]
[N01BB07, etidocaine, The risk or severity of methemoglobinemia can be increased when Cycloserine is combined with Etidocaine.]
[N05AE03, sertindole, Cycloserine may increase the neurotoxic activities of Sertindole.]
[N06AA14, melitracen, Cycloserine may increase the neurotoxic activities of Melitracen.]
[V03AZ01, ethanol, Ethanol may increase the neurotoxic activities of Cycloserine.]
[N05AF01, flupenthixol, Cycloserine may increase the neurotoxic activities of Flupentixol.]
[N05AB02, fluphenazine, Cycloserine may increase the neurotoxic activities of Fluphenazine.]
[N05AG01, fluspirilene, Cycloserine may increase the neurotoxic activities of Fluspirilene.]
[N05AL05, amisulpride, Cycloserine may increase the neurotoxic activities of Amisulpride.]
[M03AC02, gallamine, Cycloserine may increase the neurotoxic activities of Gallamine.]
[B01AA12, fluindione, The risk or severity of bleeding can be increased when Cycloserine is combined with Fluindione.]
[N05AD01, haloperidol, Cycloserine may increase the neurotoxic activities of Haloperidol.]
[N05AX07, prothipendyl, Cycloserine may increase the neurotoxic activities of Prothipendyl.]
[B05CB02, sodium citrate, Cycloserine may increase the neurotoxic activities of Sodium citrate.]
[N06AA02, imipramine, Cycloserine may increase the neurotoxic activities of Imipramine.]
[L01CD01, paclitaxel, Cycloserine may increase the neurotoxic activities of Paclitaxel.]
[N01BB08, articaine, The risk or severity of methemoglobinemia can be increased when Cycloserine is combined with Articaine.]
[J05AF04, stavudine, Cycloserine may increase the neurotoxic activities of Stavudine.]
[N06AA13, iprindole, Cycloserine may increase the neurotoxic activities of Iprindole.]
[N05AA07, chlorproethazine, Cycloserine may increase the neurotoxic activities of Chlorproethazine.]
[J04AC01, isoniazid, The risk or severity of adverse effects can be increased when Isoniazid is combined with Cycloserine.]
[A06AD11, lactulose, The therapeutic efficacy of Lactulose can be decreased when used in combination with Cycloserine.]
[S02DA01, lidocaine, The risk or severity of methemoglobinemia can be increased when Cycloserine is combined with Lidocaine.]
[J01FF02, lincomycin, Cycloserine may increase the neurotoxic activities of Lincomycin.]
[N06AA07, lofepramine, Cycloserine may increase the neurotoxic activities of Lofepramine.]
[N05AH01, loxapine, Cycloserine may increase the neurotoxic activities of Loxapine.]
[N01BB03, mepivacaine, The risk or severity of methemoglobinemia can be increased when Cycloserine is combined with Mepivacaine.]
[N05AC03, mesoridazine, Cycloserine may increase the neurotoxic activities of Mesoridazine.]
[N05AX13, paliperidone, Cycloserine may increase the neurotoxic activities of Paliperidone.]
[N05AA02, methotrimeprazine, Cycloserine may increase the neurotoxic activities of Methotrimeprazine.]
[V04CG05, methylene blue, Cycloserine may increase the neurotoxic activities of Methylene blue.]
[N05AE02, molindone, Cycloserine may increase the neurotoxic activities of Molindone.]
[N06AA09, amitriptyline, Cycloserine may increase the neurotoxic activities of Amitriptyline.]
[N06AA17, amoxapine, Cycloserine may increase the neurotoxic activities of Amoxapine.]
[S03AA01, neomycin, Cycloserine may increase the neurotoxic activities of Neomycin.]
[N05AX14, iloperidone, Cycloserine may increase the neurotoxic activities of Iloperidone.]
[N06AA10, nortriptyline, Cycloserine may increase the neurotoxic activities of Nortriptyline.]
[N06AA05, opipramol, Cycloserine may increase the neurotoxic activities of Opipramol.]
[N05AE01, oxypertine, Cycloserine may increase the neurotoxic activities of Oxypertine.]
[N05AH05, asenapine, Cycloserine may increase the neurotoxic activities of Asenapine.]
[N05AG03, penfluridol, Cycloserine may increase the neurotoxic activities of Penfluridol.]
[N05AB10, perazine, Cycloserine may increase the neurotoxic activities of Perazine.]
[N05AB03, perphenazine, Cycloserine may increase the neurotoxic activities of Perphenazine.]
[B01AA02, phenindione, The risk or severity of bleeding can be increased when Cycloserine is combined with Phenindione.]
[B01AA04, phenprocoumon, The risk or severity of bleeding can be increased when Cycloserine is combined with Phenprocoumon.]
[N05AG02, pimozide, Cycloserine may increase the neurotoxic activities of Pimozide.]
[N05AC04, pipothiazine, Cycloserine may increase the neurotoxic activities of Pipotiazine.]
[S03AA03, polymyxin B, Cycloserine may increase the neurotoxic activities of Polymyxin B.]
[N01BB04, prilocaine, The risk or severity of methemoglobinemia can be increased when Cycloserine is combined with Prilocaine.]
[S01HA05, procaine, The risk or severity of methemoglobinemia can be increased when Cycloserine is combined with Procaine.]
[N05AB04, prochlorperazine, Cycloserine may increase the neurotoxic activities of Prochlorperazine.]
[N05AA03, promazine, Cycloserine may increase the neurotoxic activities of Promazine.]
[R06AD02, promethazine, Cycloserine may increase the neurotoxic activities of Promethazine.]
[N05AC01, periciazine, Cycloserine may increase the neurotoxic activities of Periciazine.]
[N06AA11, protriptyline, Cycloserine may increase the neurotoxic activities of Protriptyline.]
[N05AX12, aripiprazole, Cycloserine may increase the neurotoxic activities of Aripiprazole.]
[C02AA02, reserpine, Reserpine may increase the neurotoxic activities of Cycloserine.]
